Status:
COMPLETED
Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients
Lead Sponsor:
Yonsei University
Collaborating Sponsors:
Inje University
Conditions:
Breast Neoplasms
Survival Analysis
Eligibility:
All Genders
18+ years
Brief Summary
The genetic polymorphisms of the cytochrome P450 may influence on the metabolism of tamoxifen. The investigators want to * evaluate the frequency or incidence of the genetic polymorphisms of cytochr...
Eligibility Criteria
Inclusion
- age ≥ 18 years
- Breast cancer patients who underwent surgery
Exclusion
- None
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01169792
Last Update
July 26 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine
Jin-Gu, Busan, South Korea, , 614-735
2
Department of Surgery, Yonsei University College of Medicine
Saedaemoon-gu, Seoul, South Korea, 120-752